neferine has been researched along with pyrazolanthrone in 1 studies
| Studies (neferine) | Trials (neferine) | Recent Studies (post-2010) (neferine) | Studies (pyrazolanthrone) | Trials (pyrazolanthrone) | Recent Studies (post-2010) (pyrazolanthrone) |
|---|---|---|---|---|---|
| 165 | 0 | 120 | 1,484 | 2 | 765 |
| Protein | Taxonomy | neferine (IC50) | pyrazolanthrone (IC50) |
|---|---|---|---|
| Chain A, Mitogen-activated protein kinase 10 | Homo sapiens (human) | 0.15 | |
| Chain A, Mitogen-activated protein kinase 10 | Homo sapiens (human) | 0.15 | |
| Chain A, Mitogen-activated protein kinase 10 | Homo sapiens (human) | 0.15 | |
| TPA: protein transporter TIM10 | Saccharomyces cerevisiae S288C | 20.2 | |
| TPA: protein transporter TIM23 | Saccharomyces cerevisiae S288C | 6.31 | |
| Serine/threonine-protein kinase/endoribonuclease IRE1 | Homo sapiens (human) | 0.72 | |
| Interferon-induced, double-stranded RNA-activated protein kinase | Homo sapiens (human) | 8 | |
| Dual specificity protein kinase TTK | Homo sapiens (human) | 0.8987 | |
| Mitogen-activated protein kinase 8 | Homo sapiens (human) | 0.921 | |
| Mitogen-activated protein kinase 9 | Homo sapiens (human) | 1.0111 | |
| Tyrosine-protein kinase JAK3 | Homo sapiens (human) | 0.957 | |
| Mitogen-activated protein kinase 10 | Homo sapiens (human) | 1.4193 | |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | 0.15 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nazim, UM; Park, SY; Yin, H | 1 |
1 other study(ies) available for neferine and pyrazolanthrone
| Article | Year |
|---|---|
Neferine treatment enhances the TRAIL‑induced apoptosis of human prostate cancer cells via autophagic flux and the JNK pathway.
Topics: Anthracenes; Autophagy; Benzylisoquinolines; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chloroquine; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Male; MAP Kinase Signaling System; Phosphorylation; Prostatic Neoplasms; TNF-Related Apoptosis-Inducing Ligand | 2020 |